8-K: Health In Tech Reports Soaring Q2 2025 Results with 86% Revenue Growth and Strategic Partnership Expansion

Health In Tech announced robust second quarter 2025 financial results, reporting $9.3 million in revenue, an 86% year-over-year increase, alongside significant growth in adjusted EBITDA and expanded distribution partnerships.

Summary

• Total revenues for the second quarter ended June 30, 2025, reached $9.3 million, marking an 86% increase year-over-year.
• First-half 2025 revenues totaled $17.3 million, representing 89% of the full-year 2024 total.
• Adjusted EBITDA for Q2 2025 was $1.6 million, up 134% year-over-year, with first-half adjusted EBITDA at $2.8 million, 1.2 times the full-year 2024 result.
• Pre-tax income for Q2 2025 was $0.8 million, more than doubling year-over-year, and first-half pre-tax income was $1.5 million, 1.7 times that of FY2024.
• The number of billed enrolled employees (EEs) increased by 5,738 year-over-year, reaching 24,839.
• The distribution network expanded to 778 partners (Brokers, TPAs, and Agencies), an 87% increase year-over-year.
• Cash balance stood at $8.1 million as of June 30, 2025.
• Accounts receivable, net, was $1.3 million as of June 30, 2025, a reduction of $0.2 million year-over-year.
• New strategic partnerships were established with Verdegard Administrators (a MedImpact company), Unified Health Plans, HILB Group, and Baily Insurance.

Sentiment

Score: 9

Explanation: The document presents exceptionally strong financial results across key metrics including revenue, adjusted EBITDA, and pre-tax income, coupled with significant expansion of distribution networks and strategic partnerships. While gross margin declined, the overall growth trajectory and management's positive outlook indicate very strong performance.

Positives

• Total revenues grew by 86% year-over-year to $9.3 million in Q2 2025, demonstrating strong top-line expansion.
• First-half revenues of $17.3 million already represent 89% of the full-year 2024 total, indicating accelerated growth.
• Adjusted EBITDA increased by 134% year-over-year to $1.6 million in Q2 2025, reflecting improved operational efficiency and profitability.
• First-half adjusted EBITDA of $2.8 million surpassed the full-year 2024 total by 1.2 times.
• Pre-tax income more than doubled year-over-year in Q2 2025 to $0.8 million, and first-half pre-tax income was 1.7 times that of FY2024.
• The number of billed enrolled employees increased by 30% year-over-year, reaching 24,839, indicating strong customer adoption.
• The distribution network expanded significantly by 87% year-over-year to 778 partners, broadening market reach.
• Strategic partnerships with Verdegard Administrators (MedImpact), Unified Health Plans, HILB Group, and Baily Insurance are expected to drive further growth and cost reduction.
• A solid cash balance of $8.1 million provides financial stability and supports future investments.
• First-half pretax income represented 8.8% of revenue, a nearly 300 basis point improvement year over year, demonstrating expense discipline.

Negatives

• GAAP gross margin decreased to 67.7% in Q2 2025 from 80.5% in Q2 2024, and to 67.3% in H1 2025 from 80.6% in H1 2024, indicating a decline in profitability per unit of revenue.
• Total liabilities increased significantly from $2,599,461 as of December 31, 2024, to $5,754,647 as of June 30, 2025.

Risks

• Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to differ materially from those expressed or implied.
• Risks and uncertainties are detailed in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other SEC filings, and may be updated over time.

Future Outlook

The company is confident in its ability to maintain strong growth momentum through the rest of the year, driven by a broader distribution footprint and multiple new relationships.

Management Comments

• Tim Johnson, CEO: "We delivered another strong quarter of profitable growth, with total revenue reaching $9.3 million—up 86% year over year—and first-half revenues already at 89% of our full-year 2024 total."
• Tim Johnson, CEO: "Our distribution network has expanded to 778 partners—an 87% increase year over year—reflecting our strategic focus on growing beyond traditional broker channels."
• Tim Johnson, CEO: "The 30% increase in billed enrolled employees and strong adoption across our network underscore the demand for our differentiated services and offering."
• Tim Johnson, CEO: "Many of our partners are now using our platform to bundle healthcare insurance with their existing services, enabling them to serve small business employer better by offering integrated, end-to-end solutions."
• Tim Johnson, CEO: "With a broader distribution footprint and multiple new relationships in place, we're confident in our ability to maintain strong growth momentum through the rest of the year."
• Julia Qian, CFO: "We're pleased with our second quarter results, which reflect strong execution and disciplined financial management across the business."
• Julia Qian, CFO: "Adjusted EBITDA for the quarter was $1.6 million, up 134% year over year, with first-half adjusted EBITDA reaching $2.8 million—1.2 times our full-year 2024 result."
• Julia Qian, CFO: "First-half pretax income represented 8.8% of revenue, a nearly 300 basis point improvement year over year, demonstrating our ability to maintain expense discipline and allocate resources effectively to drive top-line growth."
• Julia Qian, CFO: "Supported by a solid $8.1 million cash position, we remain focused on investing in high-impact initiatives and advanced technology solutions that scale efficiently and sustain profitable growth."

Industry Context

Health In Tech operates as an Insurtech platform company leveraging third-party AI technology to streamline processes in the healthcare industry. Its strategy of expanding beyond traditional broker channels and partnering with TPAs, regional healthcare benefit providers, and service platforms aligns with broader industry trends towards technology-driven efficiency, integrated solutions, and diversified distribution models to serve small and mid-size employers.

Stakeholder Impact

• Shareholders: Likely positive impact due to strong revenue and profit growth, expanded market reach, and positive future outlook.
• Employees: Potential positive impact through company growth and investment in technology, suggesting stability and opportunities.
• Customers: Positive impact through differentiated services, integrated solutions, and an easy-to-implement, intuitive AI-powered platform.
• Partners (Brokers, TPAs, Agencies): Positive impact through expanded distribution network, technology-driven solutions, and opportunities to bundle healthcare insurance with existing services, enhancing their value proposition to small businesses.

Next Steps

• Host a conference call on July 21, 2025, at 5:00 p.m. (ET) to discuss the financial results.
• Maintain strong growth momentum through the rest of the year by investing in high-impact initiatives and advanced technology solutions.

Key Dates

Recommendation

Keywords

Insurtech, Healthcare Technology, Financial Results, Q2 2025, Health In Tech, HIT, AI Platform, Insurance, EBITDA, Revenue Growth, Partnerships, SEC Filing